Accuray Incorporated (ARAY)

Accuray Incorporated is a healthcare equipment company that designs, develops, manufactures, and sells radiosurgery and radiation therapy systems used in tumor treatment. Its product portfolio includes the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system for treating primary and metastatic tumors outside the brain, as well as tumors located on or near the spine, breast, kidney, liver, lung, pancreas, and prostate. The company also markets the TomoTherapy platform, including the Radixact System, together with iDMS data management and Accuray precision treatment planning systems. In addition to its systems, Accuray provides post-contract support, installation, training, and other professional services. The company serves customers in the United States and internationally through direct sales, agents, distributors, and group purchasing organizations. Incorporated in 1990, Accuray is headquartered in Madison, Wisconsin.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.